For XAB2 rs794078 G > A polymorphism, we found that AA genotype carriers had a significantly decreased risk for developing gastric cancer (OR = 0.33; 95% CI = 0.12–0.91) in comparison to those with GG genotype. This evidence concerns the gene XAB2 and gastric cancer.